vs
Amarin Corp plc(AMRN)与NAPCO SECURITY TECHNOLOGIES, INC(NSSC)财务数据对比。点击上方公司名可切换其他公司
NAPCO SECURITY TECHNOLOGIES, INC的季度营收约是Amarin Corp plc的1.1倍($48.2M vs $45.1M),NAPCO SECURITY TECHNOLOGIES, INC净利率更高(28.0% vs -23.3%,领先51.3%),NAPCO SECURITY TECHNOLOGIES, INC同比增速更快(12.2% vs 7.0%),过去两年NAPCO SECURITY TECHNOLOGIES, INC的营收复合增速更高(-1.1% vs -18.3%)
Amarin是一家1993年成立的爱裔美籍生物制药企业,总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物,已推出处方级Omega-3脂肪酸药物Vascepa(AMR-101)。
纳普科安全技术公司1969年成立,总部位于纽约阿米蒂维尔,核心业务为研发生产各类安全产品,包括电子锁具、安防警报系统以及楼宇出入管控系统,曾用名纳普科安全系统公司。
AMRN vs NSSC — 直观对比
营收规模更大
NSSC
是对方的1.1倍
$45.1M
营收增速更快
NSSC
高出5.2%
7.0%
净利率更高
NSSC
高出51.3%
-23.3%
两年增速更快
NSSC
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $45.1M | $48.2M |
| 净利润 | $-10.5M | $13.5M |
| 毛利率 | — | 58.6% |
| 营业利润率 | 35.5% | 30.6% |
| 净利率 | -23.3% | 28.0% |
| 营收同比 | 7.0% | 12.2% |
| 净利润同比 | 33.0% | 29.0% |
| 每股收益(稀释后) | — | $0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AMRN
NSSC
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $48.2M | ||
| Q3 25 | $49.7M | $49.2M | ||
| Q2 25 | $72.7M | $50.7M | ||
| Q1 25 | $42.0M | $44.0M | ||
| Q4 24 | $62.3M | $42.9M | ||
| Q3 24 | $42.3M | $44.0M | ||
| Q2 24 | $67.5M | $50.3M |
净利润
AMRN
NSSC
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $13.5M | ||
| Q3 25 | $-7.7M | $12.2M | ||
| Q2 25 | $-14.1M | $11.6M | ||
| Q1 25 | $-15.7M | $10.1M | ||
| Q4 24 | $-48.6M | $10.5M | ||
| Q3 24 | $-25.1M | $11.2M | ||
| Q2 24 | $1.5M | $13.5M |
毛利率
AMRN
NSSC
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 58.6% | ||
| Q3 25 | 44.7% | 56.6% | ||
| Q2 25 | 69.2% | 52.8% | ||
| Q1 25 | 59.8% | 57.2% | ||
| Q4 24 | -15.4% | 57.0% | ||
| Q3 24 | 38.5% | 55.9% | ||
| Q2 24 | 63.4% | 55.3% |
营业利润率
AMRN
NSSC
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 30.6% | ||
| Q3 25 | -22.4% | 27.7% | ||
| Q2 25 | -22.0% | 23.8% | ||
| Q1 25 | -39.9% | 25.4% | ||
| Q4 24 | -84.3% | 26.0% | ||
| Q3 24 | -59.5% | 26.9% | ||
| Q2 24 | -0.8% | 27.7% |
净利率
AMRN
NSSC
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 28.0% | ||
| Q3 25 | -15.6% | 24.7% | ||
| Q2 25 | -19.4% | 22.9% | ||
| Q1 25 | -37.4% | 23.0% | ||
| Q4 24 | -78.0% | 24.4% | ||
| Q3 24 | -59.4% | 25.4% | ||
| Q2 24 | 2.3% | 26.9% |
每股收益(稀释后)
AMRN
NSSC
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.38 | ||
| Q3 25 | $-0.02 | $0.34 | ||
| Q2 25 | $-0.03 | $0.33 | ||
| Q1 25 | $-0.04 | $0.28 | ||
| Q4 24 | $-0.12 | $0.28 | ||
| Q3 24 | $-0.06 | $0.30 | ||
| Q2 24 | $0.00 | $0.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $115.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $184.8M |
| 总资产 | $645.8M | $212.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
AMRN
NSSC
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $115.4M | ||
| Q3 25 | $286.6M | $105.8M | ||
| Q2 25 | $298.7M | $99.2M | ||
| Q1 25 | $281.8M | $89.3M | ||
| Q4 24 | $294.2M | $99.2M | ||
| Q3 24 | $305.7M | $91.3M | ||
| Q2 24 | $306.7M | $70.7M |
股东权益
AMRN
NSSC
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $184.8M | ||
| Q3 25 | $458.9M | $176.1M | ||
| Q2 25 | $464.9M | $168.6M | ||
| Q1 25 | $473.7M | $161.5M | ||
| Q4 24 | $486.2M | $174.2M | ||
| Q3 24 | $531.4M | $178.6M | ||
| Q2 24 | $551.9M | $178.9M |
总资产
AMRN
NSSC
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $212.8M | ||
| Q3 25 | $659.8M | $206.0M | ||
| Q2 25 | $670.1M | $198.1M | ||
| Q1 25 | $655.7M | $190.9M | ||
| Q4 24 | $685.3M | $202.7M | ||
| Q3 24 | $750.6M | $209.9M | ||
| Q2 24 | $799.9M | $207.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $15.1M |
| 自由现金流经营现金流 - 资本支出 | — | $14.5M |
| 自由现金流率自由现金流/营收 | — | 30.1% |
| 资本支出强度资本支出/营收 | — | 1.2% |
| 现金转化率经营现金流/净利润 | — | 1.12× |
| 过去12个月自由现金流最近4个季度 | — | $53.7M |
8季度趋势,按日历期对齐
经营现金流
AMRN
NSSC
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $15.1M | ||
| Q3 25 | $-12.7M | $11.6M | ||
| Q2 25 | $16.6M | $14.6M | ||
| Q1 25 | $-12.5M | $13.4M | ||
| Q4 24 | $-13.3M | $13.5M | ||
| Q3 24 | $-2.4M | $12.0M | ||
| Q2 24 | $-2.7M | $14.3M |
自由现金流
AMRN
NSSC
| Q1 26 | — | — | ||
| Q4 25 | — | $14.5M | ||
| Q3 25 | — | $11.4M | ||
| Q2 25 | — | $14.4M | ||
| Q1 25 | — | $13.3M | ||
| Q4 24 | — | $12.4M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $13.8M |
自由现金流率
AMRN
NSSC
| Q1 26 | — | — | ||
| Q4 25 | — | 30.1% | ||
| Q3 25 | — | 23.3% | ||
| Q2 25 | — | 28.4% | ||
| Q1 25 | — | 30.3% | ||
| Q4 24 | — | 28.8% | ||
| Q3 24 | — | 25.8% | ||
| Q2 24 | — | 27.4% |
资本支出强度
AMRN
NSSC
| Q1 26 | — | — | ||
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 1.1% |
现金转化率
AMRN
NSSC
| Q1 26 | — | — | ||
| Q4 25 | — | 1.12× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 1.26× | ||
| Q1 25 | — | 1.32× | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | — | 1.08× | ||
| Q2 24 | -1.81× | 1.06× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
NSSC
暂无分部数据